Copy of Bugs, Drugs & Beyond: Targeting the Microbiome to Transform Healthcare

Mar 1 2017

Join the Janssen Human Microbiome Institute, JLABS @ TMC and Baylor College of Medicine for a one-day forum to explore the ways in which innovators from Houston and beyond are harnessing the human microbiome and advancing novel therapeutics, diagnostics and other health products. During this event, we'll hear from entrepreneurs, academics, investors, and biotech and pharma companies about a variety of product development approaches and the organizations pursuing them.

Interactive sessions will highlight:

  • Challenges in advancing to market, from IP protection to commercialization
  • Potential solutions and pathways currently being pursued across the field
  • Opportunities for collaboration

The Bugs, Drugs & Beyond QuickFire Challenge:

Are you a game-changing early-stage microbiome company? The Bugs, Drugs & Beyond QuickFire Challenge is officially open! We encourage innovators with promising ideas or research with the potential to impact patients to apply now. The winner will be awarded one year of residency at the state-of-the-art JLABS @ TMC in Houston and will be announced at the end of the event on Mar. 1st. Deadline is February 12th. Apply online today!

Dirk Gevers | Global Head, Janssen Human Microbiome Institute, Janssen R&D read bio»

Joseph F. Petrosino | Professor & Interim Chairman, Department of Molecular Virology & Microbiology, Baylor College of Medicine 

Additional Speakers To Be Confirmed


8:45 AM | Registration Opens
9:00 AM | Introductions
9:15 AM | Big Pharma's Gut Feeling on the Human Micorbiome:
  - Exploring the spectrum of Microbiome-based Therapeutics
10:00 AM | Insights from the Front Lines of Microbiome Innovation
10:45 AM | Networking Break
11:15 AM | From Regulatory to Commercialization:
  - Breaking down barriers to Microbiome Progress
12:30 PM | Networking Lunch
1:30 PM | Microbiome Gallery Walk
  - Take a tour throughout some of the most exciting micorbiome innovation
2:30 PM | Networking Break
2:45 PM | QuickFire Challenge Pitches
4:00 PM | Program Ends

$35 | General Public
$20 | Student/Academic
$45 | At the door

Speaker's Biographies:
Dirk Gevers, Ph.D. | Global Head, Janssen Human Microbiome Institute, Janssen R&D
Dirk Gevers, Ph.D., is Global Head of the Janssen Human Microbiome Institute (JHMI), where he leads efforts to expand scientific understanding and capabilities in this emerging area of science. Previously, Dirk was Senior Group Leader of Microbial Systems and Communities at the Broad Institute of MIT and Harvard, serving as a scientific liaison among various organizational components, including the institute's data generation platforms and both clinical and analytical collaborators on microbiome-related projects. Dirk's research included the characterization of the microbial imbalance associated with diseases such as Crohn's disease, type 1 diabetes and colorectal cancer. He was also involved with the National Institutes of Health Human Microbiome Project, holding a leading role in the Data Analysis Working Group. Dirk received his Ph.D. in biochemistry from Ghent University (UGent), Belgium, and completed postdoctoral training at UGent and the Massachusetts Institute of Technology in bioinformatics, comparative and evolutionary genome analysis and microbial ecology.
Connect with Dirk:   Connect on LinkedIn

Joseph F. Petrosino, Ph.D. | Professor & Interim Chair, Department of Molecular Virology & MicrobiologyBaylor College of Medicine

Joseph F. Petrosino, Ph.D. is a Professor and Interim Chairman of Molecular Virology and Microbiology at Baylor College of Medicine, where he also holds joint appointments in the Human Genome Sequencing Center and the department of ophthalmology. He received his Ph.D. from Baylor College of Medicine in 1998 and remained at Baylor for postdoctoral training in the Department of Molecular and Human Genetics until 2004 when he joined the Department of Molecular Virology and Microbiology at Baylor. Dr. Petrosino was a principal investigator for the NIH Common Fund Human Microbiome Project and, in 2011, established the Alkek Center for Metagenomics and Microbiome Research (CMMR), with its mission to develop and implement advanced technologies to understand how the microbiome impacts health and disease and translate this knowledge for better therapeutics and diagnostics. In 2014, the CMMR added four additional tenured/tenure track faculty whose research programs are targeted toward understanding microbial communities and their impact on host physiology and using this knowledge to develop therapeutic leads for translation to the clinic.

Over the past five years, the CMMR has established over 300 microbiome-related projects with over 180 collaborators worldwide. Among the most promising projects is a comprehensive microbiome analysis of 28,000+ type 1 diabetes (T1D) samples from the NIH/NIDDK TEDDY (The Environmental Determinants of Diabetes in the Young) prospective cohort which has the goal of identifying microbial taxonomic and functional associations, and potentially triggers, for T1D. Additionally, the Petrosino laboratory is employing a variety of biological and engineering approaches to isolate and fractionate live microbial cells for study of their role in human health and for use in personalized medicine applications where microbiome interventions are being considered. In 2013, Dr. Petrosino founded Diversigen, a BCM Technologies start-up where the robust pipelines built in the CMMR have been commercialized to support biotech and pharmaceutical company needs in the microbiome and metagenomics-related arenas. He has contributed to more than 80 peer-reviewed microbiome studies, and his achievements in the microbiome arena led him to be named an American Society for Microbiology Distinguished lecturer from 2012-2014.
Connect with Joseph:   Connect on LinkedIn

John P. McGovern Campus
2450 Holcombe Blvd, Suite J
Houston, TX 77021

Parking Information:
Please park in the self parking areas of the McGovern Campus. Grab a Token at the gate and bring it to the event space. We encourage carpooling and using the TMC shuttles.